Medtronic MiniMed 530G Insulin Pumps Recalled for Delivery Errors in 2026 (13,429 Units)
Medtronic recalled 13,429 MiniMed insulin pumps worldwide after identifying unintended insulin delivery errors. The issue occurs when the pump height relative to the infusion site changes, causing over-delivery or under-delivery of insulin. Patients should stop using the device and contact Medtronic for instructions.
Quick Facts at a Glance
Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
Insulin pumps deliver continuous insulin to manage diabetes. Medtronic MiniMed is a major supplier of these devices, used by adults and some pediatric patients.
Why This Is Dangerous
A gravity-related design issue can cause insulin to be delivered in excess or insufficiently, leading to dangerous swings in blood glucose.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
The recall could cause severe blood sugar events and, in rare cases, death. It disrupts ongoing diabetes management and may require medical intervention.
Practical Guidance
How to identify if yours is affected
1. Locate device model on the pump label and user guide
2. Compare with the affected list (MiniMed 530G, MMT-551, MMT-751, Paradigm/600/BLE 700 series)
3. Confirm serial numbers and UDI codes if available
4. Stop using if affected
Where to find product info
Refer to the official recall notice and FDA enforcement page at Z-1751-2026 for model and serial number checks
What timeline to expect
Refund or replacement can take 4-8 weeks after approval.
If the manufacturer is unresponsive
Escalate to consumer protection agencies
File a complaint with CPSC if needed
Consult a healthcare professional for interim diabetes management steps
How to prevent similar issues
Inspect pump height relative to infusion site to avoid over/under delivery
Keep recall notices and serial numbers for future reference
When shopping for pumps, verify safety certifications and recall status
Documentation advice
Keep the recall notice, model numbers, serial numbers, proof of purchase, and all correspondence with Medtronic MiniMed
Product Details
Model numbers: MiniMed 530G (MMT-551, MMT-751); Paradigm series, 600 series, and BLE 700 series pumps. Sold worldwide with US distribution across numerous states. Sold date and price not disclosed.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
13429 units recalled
World-wide distribution including all 50 states in the U.S.
Models affected include MiniMed 530G, MMT-551, MMT-751
Paradigm, 600 series, and BLE 700 series pumps listed in recall
Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s
Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap
Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,
Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the
Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.
Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.
Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.
Medtronic MiniMed recalled 60,880 insulin pumps sold worldwide through healthcare providers and medical distributors, including the MiniMed 630G line. The defect is gravity related and can cause insulin over-delivery or under-delivery when the pump height changes relative to the infusion site. Patients should stop using the pumps immediately and follow recall instructions.